EMPIRI scientist Thomas Gallup presents his poster "Single Cell RNA-sequencing Analysis from Clinical Trials Needle Biopsy Cores" at the GCC Single Cell Omics on October 26, 2022. GCC, an inter-institutional cooperatives based in the Texas Medical Center, brings scientist from multiple institutions for collaboration.
https://youtu.be/5fxRF8tPgVQ
San Francisco, CA, Jan 8, 2023– EMPIRI today announced that it is presenting at Biotech Showcase™ 2023. This year, registered attendees can view EMPIRI’s presentation live, and also access a recorded
At the 11th annual Texas Life Science Forum, held on November 8, 2022, EMPIRI Inc. was once again recognized as one of the Rice Alliance Most Promising Life Science Companies for our E-Slice technolog
Humbled and thrilled to receive our NIH/NCI R01 grant! It is a 5-year $3.07M grant for a prospective clinical trial with our E-Slice assay to predict Triple Negative Breast Cancer patient treatment re